These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26922707)

  • 21. Multiple arterial grafting confers survival advantage compared to percutaneous intervention with drug-eluting stents in multivessel coronary artery disease: A propensity score adjusted analysis.
    Raja SG; Benedetto U; Ilsley CD; Amrani M;
    Int J Cardiol; 2015; 189():153-8. PubMed ID: 25897895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of long-term outcomes after bypass grafting versus drug-eluting stent implantation for left main or multivessel coronary artery disease.
    Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Han M; Park SW; Serruys PW; Park SJ
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):177-185. PubMed ID: 28112467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Hannan EL
    Circulation; 2016 May; 133(22):2132-40. PubMed ID: 27151532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-Analysis of Percutaneous Coronary Intervention With Drug-Eluting Stent Versus Coronary Artery Bypass Grafting for Isolated Proximal Left Anterior Descending Coronary Disease.
    Kinnaird T; Kwok CS; Narain A; Butler R; Ossei-Gerning N; Ludman P; Moat N; Anderson R; Mamas MA
    Am J Cardiol; 2016 Oct; 118(8):1171-1177. PubMed ID: 27553097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous Coronary Intervention With Drug Eluting Stents Versus Coronary Artery Bypass Graft Surgery in Patients With Advanced Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Doulamis IP; Tzani A; Tzoumas A; Iliopoulos DC; Kampaktsis PN; Briasoulis A
    Semin Thorac Cardiovasc Surg; 2021; 33(4):958-969. PubMed ID: 33181288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials.
    Verma S; Farkouh ME; Yanagawa B; Fitchett DH; Ahsan MR; Ruel M; Sud S; Gupta M; Singh S; Gupta N; Cheema AN; Leiter LA; Fedak PW; Teoh H; Latter DA; Fuster V; Friedrich JO
    Lancet Diabetes Endocrinol; 2013 Dec; 1(4):317-28. PubMed ID: 24622417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-eluting stent placement versus coronary artery bypass surgery for unprotected left main coronary artery disease: A meta-analysis of randomized controlled trials.
    Upadhaya S; Baniya R; Madala S; Subedi SK; Khan J; Velagapudi RK; Bachuwa G
    J Card Surg; 2017 Feb; 32(2):70-79. PubMed ID: 28081585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Meta-Analysis Comparing Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Disease.
    Kodumuri V; Balasubramanian S; Vij A; Siddamsetti S; Sethi A; Khalafallah R; Khosla S
    Am J Cardiol; 2018 Apr; 121(8):924-933. PubMed ID: 29502793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year outcomes comparing percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in patients with left main coronary artery disease: A systematic review and meta-analysis.
    Zhang J; Jiang T; Hou Y; Chen F; Yang K; Sang W; Wu H; Ma Y; Xu F; Chen Y
    Atherosclerosis; 2020 Sep; 308():50-56. PubMed ID: 32713512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.
    Chang M; Ahn JM; Lee CW; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    J Am Coll Cardiol; 2016 Jul; 68(1):29-36. PubMed ID: 27364047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of Coronary Artery Bypass Graft Surgery Versus Drug-Eluting Stents in Older Adults.
    Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    J Am Geriatr Soc; 2017 Mar; 65(3):625-630. PubMed ID: 28165613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention.
    Krenn L; Kopp C; Glogar D; Lang IM; Delle-Karth G; Neunteufl T; Kreiner G; Kaider A; Bergler-Klein J; Khorsand A; Nikfardjam M; Laufer G; Maurer G; Gyöngyösi M
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1029-39. PubMed ID: 24403120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary artery bypass surgery is superior to second generation drug-eluting stents in three-vessel coronary artery disease: a propensity score matched analysis.
    Tsuneyoshi H; Komiya T; Kadota K; Shimamoto T; Sakai J; Hiraoka T; Wada K; Kaneko H; Fujimoto Y; Furuichi Y; Hata R; Jinno T; Tominaga O
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):462-468. PubMed ID: 28874027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous coronary intervention vs coronary artery bypass grafting for left main coronary artery disease? A systematic review and meta-analysis of randomized controlled trials.
    Sharma SP; Dahal K; Khatra J; Rosenfeld A; Lee J
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28371437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-Analysis Comparing Percutaneous Coronary Revascularization Using Drug-Eluting Stent Versus Coronary Artery Bypass Grafting in Patients With Left Ventricular Systolic Dysfunction.
    Cui K; Zhang D; Lyu S; Song X; Yuan F; Xu F; Zhang M
    Am J Cardiol; 2018 Nov; 122(10):1670-1676. PubMed ID: 30220418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.